In oncology, every moment of uncertainty—whether for a physician or a patient—can delay critical treatment decisions.
A pharma brand tackled this challenge by unifying their HCP and DTC oncology marketing strategies to foster clearer, more coordinated communication across the care journey. Their case study reveals how strategic alignment helped strengthen engagement with both audiences—and improved commercial outcomes. Here’s what you’ll learn:
Don’t miss this must-watch presentation from Mike Rousselle and Jen Dwyer, featured at Fierce Pharma Week 2025!